The efficacy of cholinergic drugs in patients with Alzheimer's disease - focus on the aminoacridines
K. Siegfried
Bok Engelsk
| Utgitt | K Siegfried Hoechst Ag Dept Corp Clin Dev Cl
|
|---|---|
| Opplysninger | The article reviews evidence for the efficacy of the aminoacridines (tacrine, velnacrine) in patients with probable Alzheimer's disease (AD). The discussion revolves around the question of the clinical relevance of the treatment effects observed. Other questions discussed deal with the heterogeneity of the patient population having AD, the size of the potential responder group and the limitations caused by safety problems of these compounds. The conclusion is that the effects of the aminoacridines appear to have clinical relevance in a subgroup of patients with AD. These compounds therefore truly deserve the label of 'first-generation AD agents'. But further basic and clinical research is needed to identify the responder group and predict response.
|
| Emner | |
| ISSN |
